

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.92528611 |
| 2 | modulation by symbiont of host immune response (GO:0052553) | 5.59226606 |
| 3 | positive regulation by symbiont of host defense response (GO:0052509) | 5.59226606 |
| 4 | modulation by symbiont of host defense response (GO:0052031) | 5.59226606 |
| 5 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.59226606 |
| 6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.59226606 |
| 7 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.59226606 |
| 8 | neutrophil activation involved in immune response (GO:0002283) | 5.15472999 |
| 9 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.12315183 |
| 10 | leukocyte aggregation (GO:0070486) | 5.11306921 |
| 11 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.97531549 |
| 12 | negative regulation of cell killing (GO:0031342) | 4.91221157 |
| 13 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.91221157 |
| 14 | respiratory burst (GO:0045730) | 4.78091653 |
| 15 | detection of other organism (GO:0098543) | 4.76128276 |
| 16 | response to peptidoglycan (GO:0032494) | 4.61525101 |
| 17 | detection of bacterium (GO:0016045) | 4.57241286 |
| 18 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.48648899 |
| 19 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.48648899 |
| 20 | immunoglobulin mediated immune response (GO:0016064) | 4.42440024 |
| 21 | cellular extravasation (GO:0045123) | 4.39505540 |
| 22 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.33735725 |
| 23 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.32987337 |
| 24 | macrophage activation involved in immune response (GO:0002281) | 4.15216547 |
| 25 | detection of external biotic stimulus (GO:0098581) | 4.01328976 |
| 26 | positive regulation of interferon-alpha production (GO:0032727) | 3.99265693 |
| 27 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.93181306 |
| 28 | neutrophil activation (GO:0042119) | 3.88432894 |
| 29 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.84341146 |
| 30 | granulocyte activation (GO:0036230) | 3.83923975 |
| 31 | T cell migration (GO:0072678) | 3.81403108 |
| 32 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.81004211 |
| 33 | response to host immune response (GO:0052572) | 3.81004211 |
| 34 | regulation of interferon-alpha production (GO:0032647) | 3.80634359 |
| 35 | positive regulation of mast cell activation (GO:0033005) | 3.75151405 |
| 36 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.72077915 |
| 37 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.68865795 |
| 38 | positive regulation of antigen processing and presentation (GO:0002579) | 3.64249271 |
| 39 | myeloid cell activation involved in immune response (GO:0002275) | 3.61660772 |
| 40 | detection of biotic stimulus (GO:0009595) | 3.61334650 |
| 41 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.56536583 |
| 42 | response to host (GO:0075136) | 3.54222559 |
| 43 | response to host defenses (GO:0052200) | 3.54222559 |
| 44 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.54222559 |
| 45 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.54132548 |
| 46 | regulation of gamma-delta T cell activation (GO:0046643) | 3.52696236 |
| 47 | negative regulation of interleukin-12 production (GO:0032695) | 3.51025619 |
| 48 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.48458933 |
| 49 | positive thymic T cell selection (GO:0045059) | 3.45778228 |
| 50 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.45120433 |
| 51 | negative regulation of T cell mediated immunity (GO:0002710) | 3.44475664 |
| 52 | regulation of T cell tolerance induction (GO:0002664) | 3.43785977 |
| 53 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.42121873 |
| 54 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.40833567 |
| 55 | regulation of B cell differentiation (GO:0045577) | 3.39171568 |
| 56 | negative thymic T cell selection (GO:0045060) | 3.38533930 |
| 57 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.37405900 |
| 58 | response to muramyl dipeptide (GO:0032495) | 3.35926694 |
| 59 | B cell mediated immunity (GO:0019724) | 3.35217340 |
| 60 | * leukocyte cell-cell adhesion (GO:0007159) | 3.35188990 |
| 61 | activated T cell proliferation (GO:0050798) | 3.34068643 |
| 62 | negative T cell selection (GO:0043383) | 3.32780385 |
| 63 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.31664843 |
| 64 | regulation of tolerance induction (GO:0002643) | 3.30138302 |
| 65 | regulation of mast cell activation (GO:0033003) | 3.24512226 |
| 66 | regulation of mast cell degranulation (GO:0043304) | 3.23283280 |
| 67 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.19452908 |
| 68 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.19097879 |
| 69 | positive regulation of B cell differentiation (GO:0045579) | 3.14885066 |
| 70 | regulation of antigen processing and presentation (GO:0002577) | 3.14112785 |
| 71 | B cell receptor signaling pathway (GO:0050853) | 3.10591739 |
| 72 | leukocyte degranulation (GO:0043299) | 3.10389691 |
| 73 | tolerance induction (GO:0002507) | 3.10228981 |
| 74 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 3.09889236 |
| 75 | response to type I interferon (GO:0034340) | 3.09657925 |
| 76 | cellular response to type I interferon (GO:0071357) | 3.08676997 |
| 77 | type I interferon signaling pathway (GO:0060337) | 3.08676997 |
| 78 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.07744256 |
| 79 | interferon-gamma production (GO:0032609) | 3.07725196 |
| 80 | defense response to protozoan (GO:0042832) | 3.07619983 |
| 81 | microglial cell activation (GO:0001774) | 3.06655625 |
| 82 | negative regulation of cytokine production involved in immune response (GO:0002719) | 3.06404211 |
| 83 | superoxide anion generation (GO:0042554) | 3.05996906 |
| 84 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.05927441 |
| 85 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.04741676 |
| 86 | neutrophil mediated immunity (GO:0002446) | 3.02300949 |
| 87 | positive regulation of mast cell degranulation (GO:0043306) | 3.02007179 |
| 88 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.02007179 |
| 89 | cellular response to zinc ion (GO:0071294) | 3.01241957 |
| 90 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.01146496 |
| 91 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.99028482 |
| 92 | macrophage activation (GO:0042116) | 2.97218552 |
| 93 | cellular defense response (GO:0006968) | 2.96433013 |
| 94 | mast cell activation (GO:0045576) | 2.95095409 |
| 95 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.94955180 |
| 96 | myeloid dendritic cell activation (GO:0001773) | 2.94813845 |
| 97 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.94531015 |
| 98 | positive regulation of interferon-beta production (GO:0032728) | 2.94461003 |
| 99 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.94388057 |
| 100 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.94388057 |
| 101 | reactive oxygen species biosynthetic process (GO:1903409) | 2.94344399 |
| 102 | T cell selection (GO:0045058) | 2.93779137 |
| 103 | germinal center formation (GO:0002467) | 2.92109471 |
| 104 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.91964466 |
| 105 | negative regulation of interleukin-6 production (GO:0032715) | 2.90338291 |
| 106 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.89588431 |
| 107 | cellular response to interleukin-15 (GO:0071350) | 2.89428862 |
| 108 | regulation of leukocyte degranulation (GO:0043300) | 2.88434695 |
| 109 | response to protozoan (GO:0001562) | 2.88145682 |
| 110 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.87183462 |
| 111 | myeloid leukocyte activation (GO:0002274) | 2.86969760 |
| 112 | negative regulation of phagocytosis (GO:0050765) | 2.85604535 |
| 113 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.85114892 |
| 114 | negative regulation of innate immune response (GO:0045824) | 2.84628458 |
| 115 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.84324657 |
| 116 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.84140318 |
| 117 | leukocyte migration involved in inflammatory response (GO:0002523) | 2.83181643 |
| 118 | myeloid dendritic cell differentiation (GO:0043011) | 2.82748106 |
| 119 | thymic T cell selection (GO:0045061) | 2.81548450 |
| 120 | lymphocyte chemotaxis (GO:0048247) | 2.80665819 |
| 121 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.80299358 |
| 122 | response to fungus (GO:0009620) | 2.79475129 |
| 123 | response to interleukin-15 (GO:0070672) | 2.78174291 |
| 124 | * neutrophil chemotaxis (GO:0030593) | 2.77966104 |
| 125 | detection of molecule of bacterial origin (GO:0032490) | 2.77438575 |
| 126 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.77368909 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.04832138 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.81295159 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.59126482 |
| 4 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.53801214 |
| 5 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.06998082 |
| 6 | * STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.97853909 |
| 7 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.88003892 |
| 8 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.78187451 |
| 9 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.65147084 |
| 10 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.52203042 |
| 11 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.26016259 |
| 12 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.23495405 |
| 13 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.03867771 |
| 14 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.93049946 |
| 15 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.88216083 |
| 16 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.88201995 |
| 17 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.78268549 |
| 18 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.56038907 |
| 19 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.48871791 |
| 20 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.43825232 |
| 21 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.42978982 |
| 22 | * MYB_26560356_Chip-Seq_TH2_Human | 2.37028795 |
| 23 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.33514670 |
| 24 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.27851509 |
| 25 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.23102691 |
| 26 | MAF_26560356_Chip-Seq_TH1_Human | 2.19605451 |
| 27 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.18060780 |
| 28 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.11900797 |
| 29 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.07081146 |
| 30 | SPI1_23127762_ChIP-Seq_K562_Human | 2.02760083 |
| 31 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.99922936 |
| 32 | MYB_26560356_Chip-Seq_TH1_Human | 1.94307639 |
| 33 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.92721390 |
| 34 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.90546297 |
| 35 | MYC_22102868_ChIP-Seq_BL_Human | 1.90375982 |
| 36 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.87695020 |
| 37 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.84224767 |
| 38 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.81558497 |
| 39 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.74590459 |
| 40 | * PU_27001747_Chip-Seq_BMDM_Mouse | 1.71400829 |
| 41 | * CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.67745989 |
| 42 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.66957308 |
| 43 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.63556646 |
| 44 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.60697495 |
| 45 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.54232614 |
| 46 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.53862627 |
| 47 | * VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.52202904 |
| 48 | E2F7_22180533_ChIP-Seq_HELA_Human | 1.51797460 |
| 49 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.50424191 |
| 50 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.48561241 |
| 51 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.46436449 |
| 52 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.38675741 |
| 53 | * CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.36112186 |
| 54 | MAF_26560356_Chip-Seq_TH2_Human | 1.35447148 |
| 55 | GATA1_22025678_ChIP-Seq_K562_Human | 1.32827774 |
| 56 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.32820764 |
| 57 | * CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.32469929 |
| 58 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.29958020 |
| 59 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.29827148 |
| 60 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.27909090 |
| 61 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.27628103 |
| 62 | GATA3_26560356_Chip-Seq_TH2_Human | 1.25861615 |
| 63 | * SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.21244651 |
| 64 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.20802260 |
| 65 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.17943817 |
| 66 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.16698094 |
| 67 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.16601304 |
| 68 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.14958080 |
| 69 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.14007531 |
| 70 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12290693 |
| 71 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.11242161 |
| 72 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.11082488 |
| 73 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.09405499 |
| 74 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.08393594 |
| 75 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.07996519 |
| 76 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.04162904 |
| 77 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.02934223 |
| 78 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.01056856 |
| 79 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.97583805 |
| 80 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.91822640 |
| 81 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.89985884 |
| 82 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.89938263 |
| 83 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.89503118 |
| 84 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.88853598 |
| 85 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.87964274 |
| 86 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.87872536 |
| 87 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.85446625 |
| 88 | GATA2_19941826_ChIP-Seq_K562_Human | 0.85405402 |
| 89 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.84432227 |
| 90 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.84114190 |
| 91 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.83134322 |
| 92 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.82854148 |
| 93 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 0.82693360 |
| 94 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.81982539 |
| 95 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.81720240 |
| 96 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.81672982 |
| 97 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.80851358 |
| 98 | GATA1_19941826_ChIP-Seq_K562_Human | 0.78878149 |
| 99 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.75483930 |
| 100 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.74198874 |
| 101 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.73743708 |
| 102 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.73304176 |
| 103 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.72547981 |
| 104 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.72156455 |
| 105 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.71657690 |
| 106 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 0.70477205 |
| 107 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.68226131 |
| 108 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.65914676 |
| 109 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.65563897 |
| 110 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.61798636 |
| 111 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.61127659 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.20356579 |
| 2 | MP0003436_decreased_susceptibility_to | 4.02660594 |
| 3 | MP0003303_peritoneal_inflammation | 3.60980453 |
| 4 | MP0009785_altered_susceptibility_to | 3.41082104 |
| 5 | MP0006082_CNS_inflammation | 3.30685640 |
| 6 | * MP0002419_abnormal_innate_immunity | 3.21548010 |
| 7 | * MP0005000_abnormal_immune_tolerance | 3.17695910 |
| 8 | MP0005671_abnormal_response_to | 3.13239508 |
| 9 | MP0005058_abnormal_lysosome_morphology | 3.10984233 |
| 10 | * MP0005025_abnormal_response_to | 3.01379468 |
| 11 | MP0002148_abnormal_hypersensitivity_rea | 2.98149996 |
| 12 | MP0001790_abnormal_immune_system | 2.96798618 |
| 13 | MP0005387_immune_system_phenotype | 2.96798618 |
| 14 | MP0000685_abnormal_immune_system | 2.88325935 |
| 15 | * MP0002452_abnormal_antigen_presenting | 2.80594898 |
| 16 | * MP0001800_abnormal_humoral_immune | 2.78179865 |
| 17 | MP0003724_increased_susceptibility_to | 2.73969408 |
| 18 | * MP0002723_abnormal_immune_serum | 2.64375429 |
| 19 | * MP0001819_abnormal_immune_cell | 2.56987788 |
| 20 | * MP0002420_abnormal_adaptive_immunity | 2.56965311 |
| 21 | MP0005464_abnormal_platelet_physiology | 2.39267103 |
| 22 | MP0002405_respiratory_system_inflammati | 2.31345888 |
| 23 | MP0004510_myositis | 2.25593237 |
| 24 | MP0003172_abnormal_lysosome_physiology | 2.20293450 |
| 25 | MP0001533_abnormal_skeleton_physiology | 2.15429950 |
| 26 | MP0009333_abnormal_splenocyte_physiolog | 2.02604340 |
| 27 | * MP0001845_abnormal_inflammatory_respons | 1.94699243 |
| 28 | * MP0000716_abnormal_immune_system | 1.94556711 |
| 29 | * MP0002398_abnormal_bone_marrow | 1.93225738 |
| 30 | MP0003191_abnormal_cellular_cholesterol | 1.91520936 |
| 31 | MP0003763_abnormal_thymus_physiology | 1.87234439 |
| 32 | * MP0004947_skin_inflammation | 1.81849236 |
| 33 | MP0003448_altered_tumor_morphology | 1.81067232 |
| 34 | MP0003300_gastrointestinal_ulcer | 1.80483994 |
| 35 | MP0001853_heart_inflammation | 1.79403556 |
| 36 | MP0010155_abnormal_intestine_physiology | 1.74422196 |
| 37 | * MP0000689_abnormal_spleen_morphology | 1.68311336 |
| 38 | MP0002006_tumorigenesis | 1.67124745 |
| 39 | MP0002166_altered_tumor_susceptibility | 1.66741782 |
| 40 | MP0009278_abnormal_bone_marrow | 1.66585632 |
| 41 | MP0000343_altered_response_to | 1.59517009 |
| 42 | * MP0002429_abnormal_blood_cell | 1.58519743 |
| 43 | * MP0002722_abnormal_immune_system | 1.58078151 |
| 44 | * MP0008469_abnormal_protein_level | 1.57406961 |
| 45 | MP0000858_altered_metastatic_potential | 1.56824009 |
| 46 | MP0005451_abnormal_body_composition | 1.53506241 |
| 47 | MP0003075_altered_response_to | 1.52768615 |
| 48 | MP0005310_abnormal_salivary_gland | 1.51528649 |
| 49 | MP0009840_abnormal_foam_cell | 1.47419292 |
| 50 | MP0000604_amyloidosis | 1.37747025 |
| 51 | MP0003183_abnormal_peptide_metabolism | 1.36984019 |
| 52 | MP0002998_abnormal_bone_remodeling | 1.33999555 |
| 53 | MP0009764_decreased_sensitivity_to | 1.32778366 |
| 54 | MP0005397_hematopoietic_system_phenotyp | 1.30411860 |
| 55 | MP0001545_abnormal_hematopoietic_system | 1.30411860 |
| 56 | MP0005166_decreased_susceptibility_to | 1.29781488 |
| 57 | MP0001873_stomach_inflammation | 1.28265596 |
| 58 | MP0000465_gastrointestinal_hemorrhage | 1.25432961 |
| 59 | MP0002396_abnormal_hematopoietic_system | 1.16169530 |
| 60 | MP0000569_abnormal_digit_pigmentation | 1.15276185 |
| 61 | MP0000703_abnormal_thymus_morphology | 1.11727680 |
| 62 | MP0003690_abnormal_glial_cell | 1.08544133 |
| 63 | * MP0002933_joint_inflammation | 1.08487258 |
| 64 | MP0005174_abnormal_tail_pigmentation | 1.07980835 |
| 65 | * MP0001851_eye_inflammation | 1.05633785 |
| 66 | MP0008004_abnormal_stomach_pH | 1.05467581 |
| 67 | MP0004808_abnormal_hematopoietic_stem | 1.03048513 |
| 68 | MP0004381_abnormal_hair_follicle | 1.02181184 |
| 69 | MP0010307_abnormal_tumor_latency | 1.00006431 |
| 70 | MP0003566_abnormal_cell_adhesion | 0.99285055 |
| 71 | MP0003866_abnormal_defecation | 0.98359319 |
| 72 | MP0005076_abnormal_cell_differentiation | 0.97512954 |
| 73 | MP0005390_skeleton_phenotype | 0.96871804 |
| 74 | MP0009763_increased_sensitivity_to | 0.95996938 |
| 75 | MP0005167_abnormal_blood-brain_barrier | 0.91547128 |
| 76 | MP0003828_pulmonary_edema | 0.88700159 |
| 77 | MP0000490_abnormal_crypts_of | 0.88119344 |
| 78 | MP0003806_abnormal_nucleotide_metabolis | 0.81430054 |
| 79 | MP0003656_abnormal_erythrocyte_physiolo | 0.79779590 |
| 80 | MP0003329_amyloid_beta_deposits | 0.78784304 |
| 81 | MP0000249_abnormal_blood_vessel | 0.77642223 |
| 82 | MP0004782_abnormal_surfactant_physiolog | 0.76973941 |
| 83 | MP0005023_abnormal_wound_healing | 0.75986357 |
| 84 | MP0009765_abnormal_xenobiotic_induced | 0.68318193 |
| 85 | MP0005164_abnormal_response_to | 0.67666394 |
| 86 | MP0001663_abnormal_digestive_system | 0.67238539 |
| 87 | * MP0003795_abnormal_bone_structure | 0.66977236 |
| 88 | MP0010352_gastrointestinal_tract_polyps | 0.66794626 |
| 89 | MP0003453_abnormal_keratinocyte_physiol | 0.66748755 |
| 90 | MP0002277_abnormal_respiratory_mucosa | 0.64200039 |
| 91 | MP0002136_abnormal_kidney_physiology | 0.64156804 |
| 92 | MP0001986_abnormal_taste_sensitivity | 0.63619509 |
| 93 | MP0008874_decreased_physiological_sensi | 0.62220189 |
| 94 | MP0008260_abnormal_autophagy | 0.61860642 |
| 95 | MP0002019_abnormal_tumor_incidence | 0.61786342 |
| 96 | MP0000015_abnormal_ear_pigmentation | 0.61404621 |
| 97 | MP0000371_diluted_coat_color | 0.61385076 |
| 98 | MP0000920_abnormal_myelination | 0.61072446 |
| 99 | MP0002132_abnormal_respiratory_system | 0.60992203 |
| 100 | MP0005075_abnormal_melanosome_morpholog | 0.57874189 |
| 101 | MP0002138_abnormal_hepatobiliary_system | 0.55645441 |
| 102 | MP0004883_abnormal_blood_vessel | 0.54520013 |
| 103 | MP0002877_abnormal_melanocyte_morpholog | 0.54258104 |
| 104 | MP0003091_abnormal_cell_migration | 0.53564594 |
| 105 | MP0008873_increased_physiological_sensi | 0.53457077 |
| 106 | MP0000609_abnormal_liver_physiology | 0.52632730 |
| 107 | MP0001958_emphysema | 0.52592712 |
| 108 | MP0004130_abnormal_muscle_cell | 0.52553001 |
| 109 | MP0003045_fibrosis | 0.49629618 |
| 110 | MP0005319_abnormal_enzyme/_coenzyme | 0.49552469 |
| 111 | MP0009115_abnormal_fat_cell | 0.48240105 |
| 112 | MP0005381_digestive/alimentary_phenotyp | 0.47284312 |
| 113 | MP0000767_abnormal_smooth_muscle | 0.46759591 |
| 114 | MP0003186_abnormal_redox_activity | 0.46411889 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 7.32197732 |
| 2 | * Recurrent abscess formation (HP:0002722) | 6.81727390 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 6.47173494 |
| 4 | Abnormality of macrophages (HP:0004311) | 5.13707334 |
| 5 | * Recurrent gram-negative bacterial infections (HP:0005420) | 5.03518600 |
| 6 | Vacuolated lymphocytes (HP:0001922) | 4.86995223 |
| 7 | Systemic lupus erythematosus (HP:0002725) | 4.68699388 |
| 8 | Mediastinal lymphadenopathy (HP:0100721) | 4.56930804 |
| 9 | Increased cerebral lipofuscin (HP:0011813) | 4.43136926 |
| 10 | Recurrent fungal infections (HP:0002841) | 4.40710853 |
| 11 | Recurrent skin infections (HP:0001581) | 4.30061805 |
| 12 | Obstructive lung disease (HP:0006536) | 4.26449395 |
| 13 | Chronic obstructive pulmonary disease (HP:0006510) | 4.26449395 |
| 14 | Myositis (HP:0100614) | 4.21907082 |
| 15 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.04690978 |
| 16 | Stomatitis (HP:0010280) | 3.98857220 |
| 17 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.85203106 |
| 18 | Dysostosis multiplex (HP:0000943) | 3.72497574 |
| 19 | Pustule (HP:0200039) | 3.59254379 |
| 20 | Orchitis (HP:0100796) | 3.58263637 |
| 21 | Recurrent viral infections (HP:0004429) | 3.56061082 |
| 22 | Autoimmune thrombocytopenia (HP:0001973) | 3.51445873 |
| 23 | Recurrent cutaneous fungal infections (HP:0011370) | 3.46814209 |
| 24 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.46814209 |
| 25 | * Gingivitis (HP:0000230) | 3.43269787 |
| 26 | Abnormality of glycolipid metabolism (HP:0010969) | 3.40926117 |
| 27 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.40926117 |
| 28 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.40926117 |
| 29 | Retrobulbar optic neuritis (HP:0100654) | 3.36140682 |
| 30 | Optic neuritis (HP:0100653) | 3.36140682 |
| 31 | Cellulitis (HP:0100658) | 3.18076924 |
| 32 | Chronic otitis media (HP:0000389) | 3.17706133 |
| 33 | Meningitis (HP:0001287) | 3.17465963 |
| 34 | Vasculitis (HP:0002633) | 3.01889149 |
| 35 | Abnormality of T cell number (HP:0011839) | 3.01220677 |
| 36 | T lymphocytopenia (HP:0005403) | 2.98689971 |
| 37 | Nasal polyposis (HP:0100582) | 2.98505420 |
| 38 | Glomerulonephritis (HP:0000099) | 2.92270547 |
| 39 | Disinhibition (HP:0000734) | 2.91179662 |
| 40 | Mucopolysacchariduria (HP:0008155) | 2.90463688 |
| 41 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.90463688 |
| 42 | Interstitial pulmonary disease (HP:0006530) | 2.89288471 |
| 43 | Amyloidosis (HP:0011034) | 2.86818349 |
| 44 | Keratoconjunctivitis (HP:0001096) | 2.86253133 |
| 45 | IgM deficiency (HP:0002850) | 2.84107688 |
| 46 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.83864384 |
| 47 | Loss of speech (HP:0002371) | 2.80362099 |
| 48 | Urticaria (HP:0001025) | 2.76788193 |
| 49 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.72977108 |
| 50 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.72977108 |
| 51 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.72977108 |
| 52 | Spontaneous hematomas (HP:0007420) | 2.71750476 |
| 53 | Abnormality of the nasal mucosa (HP:0000433) | 2.71069556 |
| 54 | Chest pain (HP:0100749) | 2.67286313 |
| 55 | Granulocytopenia (HP:0001913) | 2.64173743 |
| 56 | Axonal loss (HP:0003447) | 2.61130396 |
| 57 | Pulmonary infiltrates (HP:0002113) | 2.59085896 |
| 58 | Pulmonary embolism (HP:0002204) | 2.56327138 |
| 59 | Panhypogammaglobulinemia (HP:0003139) | 2.52622132 |
| 60 | Hemoptysis (HP:0002105) | 2.52361192 |
| 61 | Petechiae (HP:0000967) | 2.52034199 |
| 62 | Episodic fever (HP:0001954) | 2.49951087 |
| 63 | Increased serum ferritin (HP:0003281) | 2.49898281 |
| 64 | Abnormality of T cells (HP:0002843) | 2.48732834 |
| 65 | Purpura (HP:0000979) | 2.47872465 |
| 66 | Osteomyelitis (HP:0002754) | 2.47262299 |
| 67 | Hepatosplenomegaly (HP:0001433) | 2.44553949 |
| 68 | Recurrent bronchitis (HP:0002837) | 2.44236819 |
| 69 | Inflammation of the large intestine (HP:0002037) | 2.43463431 |
| 70 | Arterial thrombosis (HP:0004420) | 2.43132922 |
| 71 | Basal ganglia calcification (HP:0002135) | 2.42381555 |
| 72 | Recurrent pneumonia (HP:0006532) | 2.41328579 |
| 73 | Autoimmune hemolytic anemia (HP:0001890) | 2.36946481 |
| 74 | Agnosia (HP:0010524) | 2.35668104 |
| 75 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.34428703 |
| 76 | Increased IgM level (HP:0003496) | 2.32391669 |
| 77 | Hypochromic anemia (HP:0001931) | 2.30682173 |
| 78 | Prolonged bleeding time (HP:0003010) | 2.30027650 |
| 79 | Gastrointestinal inflammation (HP:0004386) | 2.29505546 |
| 80 | Epistaxis (HP:0000421) | 2.26556634 |
| 81 | Anorexia (HP:0002039) | 2.26408684 |
| 82 | Hematochezia (HP:0002573) | 2.25041942 |
| 83 | Colitis (HP:0002583) | 2.25030418 |
| 84 | Abnormality of iron homeostasis (HP:0011031) | 2.23079336 |
| 85 | Eosinophilia (HP:0001880) | 2.22293067 |
| 86 | Gingival bleeding (HP:0000225) | 2.21647025 |
| 87 | * Leukocytosis (HP:0001974) | 2.18586131 |
| 88 | Lymphopenia (HP:0001888) | 2.18389243 |
| 89 | Prostate neoplasm (HP:0100787) | 2.18257373 |
| 90 | Myocardial infarction (HP:0001658) | 2.18142818 |
| 91 | Keratoconjunctivitis sicca (HP:0001097) | 2.16151293 |
| 92 | Mutism (HP:0002300) | 2.15309911 |
| 93 | Hypergammaglobulinemia (HP:0010702) | 2.15017830 |
| 94 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.14441133 |
| 95 | Combined immunodeficiency (HP:0005387) | 2.14195484 |
| 96 | Cheilitis (HP:0100825) | 2.13878707 |
| 97 | Gangrene (HP:0100758) | 2.10231607 |
| 98 | Premature loss of primary teeth (HP:0006323) | 2.07452886 |
| 99 | Thoracic kyphosis (HP:0002942) | 2.06750877 |
| 100 | Recurrent lower respiratory tract infections (HP:0002783) | 2.05790717 |
| 101 | Gastrointestinal infarctions (HP:0005244) | 2.04044529 |
| 102 | Skin ulcer (HP:0200042) | 2.03782113 |
| 103 | Abnormality of T cell physiology (HP:0011840) | 2.03691730 |
| 104 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.02516960 |
| 105 | Polyneuropathy (HP:0001271) | 2.02409778 |
| 106 | Thyroiditis (HP:0100646) | 2.02362807 |
| 107 | Spondylolisthesis (HP:0003302) | 2.02300883 |
| 108 | Abnormality of eosinophils (HP:0001879) | 2.01535253 |
| 109 | Severe combined immunodeficiency (HP:0004430) | 2.01079194 |
| 110 | Abnormality of the pleura (HP:0002103) | 2.00378098 |
| 111 | Nephritis (HP:0000123) | 1.99987477 |
| 112 | Restrictive lung disease (HP:0002091) | 1.99775296 |
| 113 | Thick nail (HP:0001805) | 1.98149241 |
| 114 | Encephalitis (HP:0002383) | 1.97835097 |
| 115 | Increased CSF protein (HP:0002922) | 1.97725640 |
| 116 | Abnormality of the lumbar spine (HP:0100712) | 1.96875775 |
| 117 | Sepsis (HP:0100806) | 1.96760519 |
| 118 | Abnormality of complement system (HP:0005339) | 1.96661236 |
| 119 | Increased IgE level (HP:0003212) | 1.96578457 |
| 120 | Upper motor neuron abnormality (HP:0002127) | 1.95471751 |
| 121 | Joint swelling (HP:0001386) | 1.95183325 |
| 122 | Glomerulopathy (HP:0100820) | 1.93973630 |
| 123 | Neuronal loss in central nervous system (HP:0002529) | 1.89973743 |
| 124 | Microcytic anemia (HP:0001935) | 1.89688426 |
| 125 | Slow saccadic eye movements (HP:0000514) | 1.87936468 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.61101815 |
| 2 | BLK | 3.82989293 |
| 3 | TXK | 3.28981232 |
| 4 | RIPK4 | 3.26844850 |
| 5 | IRAK4 | 3.01689539 |
| 6 | TYK2 | 2.99152606 |
| 7 | MAP3K14 | 2.83443085 |
| 8 | TBK1 | 2.80844314 |
| 9 | PRPF4B | 2.60998478 |
| 10 | JAK3 | 2.40238822 |
| 11 | ZAP70 | 2.39998235 |
| 12 | KIT | 2.25161749 |
| 13 | IKBKE | 2.24849971 |
| 14 | STK10 | 2.18660180 |
| 15 | CSK | 2.10177076 |
| 16 | ERN1 | 2.08387458 |
| 17 | JAK1 | 1.97686601 |
| 18 | IRAK3 | 1.80051126 |
| 19 | ITK | 1.76623996 |
| 20 | HCK | 1.72764834 |
| 21 | SYK | 1.69603269 |
| 22 | TGFBR2 | 1.69497427 |
| 23 | FES | 1.68265214 |
| 24 | BTK | 1.67697264 |
| 25 | IKBKB | 1.64803153 |
| 26 | CSF1R | 1.56847980 |
| 27 | EPHB1 | 1.56316597 |
| 28 | GRK6 | 1.51723019 |
| 29 | TEC | 1.46637986 |
| 30 | * LCK | 1.43102194 |
| 31 | TRIB3 | 1.41592624 |
| 32 | FGR | 1.36752025 |
| 33 | MAP3K13 | 1.33291916 |
| 34 | CLK1 | 1.33256559 |
| 35 | FGFR4 | 1.30434443 |
| 36 | TAOK3 | 1.28865910 |
| 37 | MARK3 | 1.22915177 |
| 38 | LYN | 1.22433221 |
| 39 | MAP2K3 | 1.21178473 |
| 40 | NME2 | 1.19567186 |
| 41 | LRRK2 | 1.13671678 |
| 42 | JAK2 | 1.10754179 |
| 43 | TTN | 1.10563558 |
| 44 | KSR2 | 1.09748335 |
| 45 | FGFR3 | 1.08390630 |
| 46 | TAOK2 | 1.07184775 |
| 47 | PKN2 | 1.06287574 |
| 48 | RPS6KA4 | 1.04549352 |
| 49 | PIM1 | 0.97116482 |
| 50 | PBK | 0.93350693 |
| 51 | TESK2 | 0.93067230 |
| 52 | CAMKK2 | 0.92112038 |
| 53 | BMPR2 | 0.89006745 |
| 54 | NEK9 | 0.86407679 |
| 55 | TRPM7 | 0.85945538 |
| 56 | SIK2 | 0.84579059 |
| 57 | MST4 | 0.84251538 |
| 58 | MAP3K10 | 0.84174999 |
| 59 | KDR | 0.83981841 |
| 60 | MARK2 | 0.82374866 |
| 61 | IRAK1 | 0.79616131 |
| 62 | CDC42BPA | 0.79175272 |
| 63 | CHUK | 0.78923886 |
| 64 | MAP3K11 | 0.75897937 |
| 65 | MAPK12 | 0.75432065 |
| 66 | MAP3K6 | 0.75302187 |
| 67 | CAMK1D | 0.75049196 |
| 68 | MST1R | 0.74040282 |
| 69 | BMX | 0.71627735 |
| 70 | GRK7 | 0.71482119 |
| 71 | MAPK7 | 0.70151813 |
| 72 | PTK6 | 0.69780925 |
| 73 | PIM2 | 0.69121792 |
| 74 | PRKCQ | 0.69120836 |
| 75 | RIPK1 | 0.66613542 |
| 76 | PRKD2 | 0.64268214 |
| 77 | MOS | 0.61575093 |
| 78 | IRAK2 | 0.61249536 |
| 79 | ICK | 0.60214084 |
| 80 | EGFR | 0.59244183 |
| 81 | STK4 | 0.58293164 |
| 82 | MATK | 0.56733459 |
| 83 | MAP3K2 | 0.56432947 |
| 84 | MAP3K5 | 0.56123033 |
| 85 | FYN | 0.52700062 |
| 86 | NLK | 0.52694661 |
| 87 | CAMKK1 | 0.51729712 |
| 88 | ABL1 | 0.51682779 |
| 89 | PIK3CG | 0.51460529 |
| 90 | RET | 0.49442597 |
| 91 | PAK4 | 0.49415710 |
| 92 | RPS6KA2 | 0.47960111 |
| 93 | PDK1 | 0.47884897 |
| 94 | MAP3K12 | 0.47852689 |
| 95 | MAP3K3 | 0.47199506 |
| 96 | MAP2K6 | 0.47088120 |
| 97 | TESK1 | 0.46850737 |
| 98 | * PRKCD | 0.46393505 |
| 99 | RPS6KA6 | 0.46281678 |
| 100 | SGK3 | 0.45154263 |
| 101 | HIPK2 | 0.44424400 |
| 102 | EPHA3 | 0.43683838 |
| 103 | TYRO3 | 0.41038141 |
| 104 | CAMK1G | 0.40873188 |
| 105 | MAP3K7 | 0.40601112 |
| 106 | STK11 | 0.39404687 |
| 107 | DYRK1B | 0.38383696 |
| 108 | ABL2 | 0.38187578 |
| 109 | MAPKAPK2 | 0.38010925 |
| 110 | SMG1 | 0.37905886 |
| 111 | IGF1R | 0.37007952 |
| 112 | RPS6KL1 | 0.36562762 |
| 113 | RPS6KC1 | 0.36562762 |
| 114 | SIK3 | 0.35372436 |
| 115 | MAP2K4 | 0.34733584 |
| 116 | CDK12 | 0.34530777 |
| 117 | CDK6 | 0.34130833 |
| 118 | ALK | 0.31356768 |
| 119 | PDGFRB | 0.31248755 |
| 120 | TNK2 | 0.30241392 |
| 121 | DMPK | 0.29721921 |
| 122 | PDPK1 | 0.29211617 |
| 123 | MAPK4 | 0.26941501 |
| 124 | MAP3K8 | 0.26699579 |
| 125 | INSR | 0.26561904 |
| 126 | TAOK1 | 0.26333042 |
| 127 | CDK4 | 0.25896637 |
| 128 | STK24 | 0.25559479 |
| 129 | YES1 | 0.24028501 |
| 130 | MAP3K1 | 0.23974887 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.30250925 |
| 2 | * Leishmaniasis_Homo sapiens_hsa05140 | 3.25671530 |
| 3 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.79134959 |
| 4 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.63631265 |
| 5 | Other glycan degradation_Homo sapiens_hsa00511 | 2.41223330 |
| 6 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.36753511 |
| 7 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.32675633 |
| 8 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.31018720 |
| 9 | Lysosome_Homo sapiens_hsa04142 | 2.30492272 |
| 10 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.29304176 |
| 11 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.15210202 |
| 12 | Measles_Homo sapiens_hsa05162 | 2.14304894 |
| 13 | * Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.14214136 |
| 14 | * Tuberculosis_Homo sapiens_hsa05152 | 2.14040318 |
| 15 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.03638851 |
| 16 | Allograft rejection_Homo sapiens_hsa05330 | 2.02842518 |
| 17 | * Pertussis_Homo sapiens_hsa05133 | 2.02549013 |
| 18 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.01700931 |
| 19 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.01408002 |
| 20 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.98262162 |
| 21 | * Legionellosis_Homo sapiens_hsa05134 | 1.89411901 |
| 22 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.79920301 |
| 23 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.76737903 |
| 24 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.74864907 |
| 25 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.73483336 |
| 26 | * Malaria_Homo sapiens_hsa05144 | 1.72014025 |
| 27 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.69029686 |
| 28 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.64026830 |
| 29 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.58300802 |
| 30 | Salmonella infection_Homo sapiens_hsa05132 | 1.57850325 |
| 31 | Asthma_Homo sapiens_hsa05310 | 1.55690511 |
| 32 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.55306381 |
| 33 | * Phagosome_Homo sapiens_hsa04145 | 1.55064207 |
| 34 | * Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.52931729 |
| 35 | Shigellosis_Homo sapiens_hsa05131 | 1.49072522 |
| 36 | Influenza A_Homo sapiens_hsa05164 | 1.47986562 |
| 37 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.43241463 |
| 38 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.40391148 |
| 39 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.35490831 |
| 40 | * Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.35097390 |
| 41 | Apoptosis_Homo sapiens_hsa04210 | 1.34747503 |
| 42 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.34639188 |
| 43 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.23692546 |
| 44 | Hepatitis B_Homo sapiens_hsa05161 | 1.20089953 |
| 45 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.18853952 |
| 46 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.18374524 |
| 47 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.05490511 |
| 48 | * Viral myocarditis_Homo sapiens_hsa05416 | 1.02579803 |
| 49 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.01804843 |
| 50 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.98156270 |
| 51 | Platelet activation_Homo sapiens_hsa04611 | 0.96428728 |
| 52 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.96118173 |
| 53 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.95821638 |
| 54 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.90797755 |
| 55 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.89935929 |
| 56 | Hepatitis C_Homo sapiens_hsa05160 | 0.88808125 |
| 57 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.82663431 |
| 58 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.81269474 |
| 59 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.80374005 |
| 60 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.78491790 |
| 61 | * Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.76728005 |
| 62 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.76338603 |
| 63 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.70764599 |
| 64 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.62614486 |
| 65 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.62283312 |
| 66 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.61940900 |
| 67 | * Amoebiasis_Homo sapiens_hsa05146 | 0.61280613 |
| 68 | Endocytosis_Homo sapiens_hsa04144 | 0.58319481 |
| 69 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.58087729 |
| 70 | * Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.52910182 |
| 71 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.51433763 |
| 72 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.51017147 |
| 73 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.48692780 |
| 74 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.48199526 |
| 75 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.47932924 |
| 76 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.47721845 |
| 77 | Prion diseases_Homo sapiens_hsa05020 | 0.47026146 |
| 78 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.46340820 |
| 79 | Endometrial cancer_Homo sapiens_hsa05213 | 0.45787086 |
| 80 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.44097821 |
| 81 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.42120130 |
| 82 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.41093440 |
| 83 | * HTLV-I infection_Homo sapiens_hsa05166 | 0.40992261 |
| 84 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.40442374 |
| 85 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.39586036 |
| 86 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.38245698 |
| 87 | Bladder cancer_Homo sapiens_hsa05219 | 0.38221323 |
| 88 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.37938499 |
| 89 | Colorectal cancer_Homo sapiens_hsa05210 | 0.35764393 |
| 90 | * Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.35418584 |
| 91 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.33999394 |
| 92 | Insulin resistance_Homo sapiens_hsa04931 | 0.33336392 |
| 93 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.33161968 |
| 94 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.31865490 |
| 95 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.31802914 |
| 96 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.31394966 |
| 97 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.31339462 |
| 98 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.29106363 |
| 99 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.27765884 |
| 100 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.24584640 |
| 101 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.22521757 |
| 102 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.16841272 |
| 103 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.16796221 |
| 104 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.16562990 |
| 105 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.15819713 |
| 106 | Adherens junction_Homo sapiens_hsa04520 | 0.15763098 |
| 107 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.15052483 |
| 108 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.14628308 |
| 109 | ABC transporters_Homo sapiens_hsa02010 | 0.13650409 |
| 110 | * Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.12891813 |

